Candidiasis, unspecified
ICD-10 B43.9 is a billable code used to indicate a diagnosis of candidiasis, unspecified.
Candidiasis, also known as thrush or yeast infection, is a fungal infection caused by the overgrowth of Candida species, primarily Candida albicans. This condition can affect various parts of the body, including the mouth, throat, esophagus, and genital area. In immunocompromised patients, such as those with HIV/AIDS, cancer, or those undergoing immunosuppressive therapy, the risk of developing candidiasis significantly increases. Symptoms may vary depending on the site of infection but often include itching, irritation, and discomfort. In severe cases, candidiasis can lead to systemic infections, particularly in patients with weakened immune systems. Diagnosis typically involves clinical evaluation and may be confirmed through laboratory tests, including cultures or microscopic examination of affected tissues. Treatment usually involves antifungal medications, such as fluconazole or itraconazole, which can be administered orally or intravenously, depending on the severity of the infection. It is crucial for healthcare providers to monitor patients closely, especially those who are immunocompromised, to prevent complications associated with candidiasis.
Detailed patient history, including immunocompromised status and treatment response.
Patients presenting with recurrent candidiasis or systemic infections.
Consideration of antifungal resistance and alternative treatments.
Comprehensive documentation of symptoms and treatment plans.
Patients with oral thrush or vaginal yeast infections.
Monitoring for recurrence and patient education on prevention.
Used when laboratory confirmation of candidiasis is required.
Document the reason for testing and any relevant clinical findings.
Infectious disease specialists may order this test more frequently.
Common symptoms include itching, irritation, and discomfort in the affected area, which may vary depending on the site of infection.
Candidiasis is typically treated with antifungal medications such as fluconazole or itraconazole, with the choice depending on the severity and site of infection.
